CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that its Chief Executive Officer, Steven Engle, will present a company overview at the 3rd Annual Longevity Therapeutics Conference, being held virtually on January 26 - 28, 2021.
January 20, 2021
· 4 min read